Summary The release of components from human kidney tumour xenografts (GYL) and human foetal kidney explants maintained in nude mice has been studied. The GYL tumour released antigens into the serum which could be detected by the generation of antibodies following cross-immunisation of closely related hairy litter mate (HLM) mice. The production of anti-GYL antibody was monitored by an 1125 binding assay using viable GYL tumour cells. In 2/16 hairy litter mate mice, cell surface antibody binding by GYL cells was twice that found with 8 other human tumour cell lines (including 2 other kidney cancer cell lines). Absorption of these antisera with 107 GYL tumour cells completely abolished this response, where 50%, 38% and 25% of activity remained following absorption with; a normal kidney cell line, a homogenate of normal kidney and a mixed pool of human tumour cells. Six out of 8 GYL tumour bearing nude mice tested had elevated plasma levels of HCG. Absorption of the HLM antisera with an excess of commercial HCG abrogated 1125 binding by only 15%, suggesting that antibody production was not directed primarily against ectopic HCG.
There has been considerable interest in the immunobiology of human cancers since the demonstration of both cellular and humoral immunity to neuroblastomas (Hellstrom et al., 1968) . Evidence that human renal cancers may be influenced by the hosts' own immune system is thought to be provided by occasional reports of the spontaneous regression of metastases following surgical excision of a primary kidney tumour (Freed et al., 1977) and antibodies directed against human renal cancer have been detected in the serum of some patients with this disease (Ackerman, 1975; Dekernion et al., 1979; Ueda et al., 1981) . However, the concept that human tumour cells may display type specific determinants which are probably only weakly antigenic (Herberman et al., 1977) , has never been convincingly demonstrated.
The development of the nude mouse as a host for human tumours has made it possible to study many human cancers in vivo and it has been shown that human kidney tumours xenografted into nude mice retain morphological and behavioural features of the original tumour (Katsuoka et al., 1976; Matthews et al., 1982) . Several investigators have shown that human tumours growing as xenografts in nude mice retain their ability to release tumour products such as carcinoembryonic antigen (Sordat et al., 1974) , human chorionic gonadatropin (Kameya et al., 1976) and B2 microglobulin (Dipersio et al., 1980) . The purpose of this study was to investigate the release of cellular components from xenografted human kidney tumours by using the nude mouse hairy litter mate model previously developed for the study of pancreatic cancer .
Materials and methods

Animals
Outbred congenitally athymic nude mice (nu/nu) and their related hairy litter mates [HLM] (nu/+) were obtained from the Imperial Cancer Research Fund Laboratories (Mill Hill, UK) when aged 4-6 weeks. The nude animals were maintained on sterile diet in negative pressure isolators, while the HLM mice were housed conventionally.
Xenografts
A human kidney tumour was established as a xenograft (GYL) in nude mice as previously described (Matthews et al., 1982) . Xenografted tumours were grown in 75 nude mice and on reaching a size of 1.5cms diameter the mice were exsanguinated by cardiac puncture and the resulting serum (30ml) pooled and stored at -70°. A total of 35 human foetal kidneys (8-14 weeks gestation) obtained from the tissue bank at the Royal Marsden Hospital (London) were minced and injected subcutaneously into 40 nude mice. Prior to regression of the s.c. nodules that formed (4-6 weeks), mice were exsanguinated, the serum pooled and the nodule examined histologically.
Tissue culture Cell lines from kidney tumours GYL and WIL (Matthews et al., 1982) , colonic cancer CAS (Davies et al., 1981) and pancreatic cancer WAD were established in this laboratory from tumour xenografted into nude mice; GER was established directly from a primary pancreatic cancer explant (Grant et al., 1979) ; CAKI-1, a kidney tumour (Fogh & Trempe, 1975) and RT4, a bladder tumour (Rigby & Franks, 1970) were kindly supplied by Drs. Fogh and Franks respectively. A colonic tumour HT29 (Fogh & Trempe, 1975) and breast cancer "MDA 157" (Young et al., 1974) were also available for study. (Sprent & Miller, 1972) , we were unable to detect free antibody to the GYL kidney tumour in the serum of the tumour bearing nude mice, findings similar to those previously identified in human pancreatic cancer bearing nude mice . Cross immunisation of the closely related immunocompetent hairy litter mates with serum from the kidney tumour bearing nudes led to the production of antibodies directed against the circulating components released from human tumour cells during growth. While antibody levels in the HLM mice were at least twice those in control HLM mice, only 2 of the mice produced significantly higher anti-GYL antibody levels (binding ratio >2) when tested against the other 8 human cancer cell lines. This result may reflect the heterogenicity of the outbred HLM mouse. The two other renal cancer cell lines (CAKI-1 and WIL) in the panel did not selectively bind these antisera, suggesting that the antibodies generated by HLM were predominantly directed against the GYL tumour itself. This observation was further supported by the finding that the absorption of the antisera with a mixed pool of human tumour cells (including CAKI-I and WIL kidney cancer cell line), a normal kidney cell line and a homogenate of normal kidney did not completely abolish the antibody response. This implies that some of the antibody is directed against GYL tumour components not present on other tumours or normal kidney.
Kidney tumours have been shown to release a variety of inappropriate hormones and other tumour related products (Sufrin et al., 1977; Chisholm, 1982) . Although the GYL tumour did not secrete CEA, AFP, PTH or renin, 6/8 tumour bearing nude mice had raised levels of HCG, and this finding supports clinical evidence that renal tumours may occasionally secrete HCG (Castleman et al., 1972; Chilsolm, 1974 One of the alterations to the cell surface that may occur during the process of neoplastic transformation is the re-expression of foetal antigens (Uriel, 1979) . We used the HLM model to try and compare the release of cell surface components from xenografted human foetal kidney tissue with components released by the GYL tumour. However, in common with other reports of human foetal tissue xenografted into nude mice, we found that the foetal kidney tissue would not maintain over a long period (Povlsen et al., 1974; Bastert et al., 1977; Usadel et al., 1977) . Careful scrutiny of the histological sections of the foetal kidney xenografts showed only a very few mitotic figures compared to the kidney tumour xenografts. The absence of antibody to the circulating components of the foetal kidney tissue is probably related to the small size of the xenograft and to the paucity of actively dividing cells.
In common with our findings for pancreatic cancer this crossimmunisation technique offers a way of producing antibodies directed against antigens that are constantly released from the tumour cell surface. The spleen cells from these animals are currently being used to produce monoclonal antibodies in order to identify and chacterise these antigens.
